CM Life Sciences, Inc. (CMLFU) 은(는) 상장 기업입니다 금융 섹터의 Shell Companies 산업에서 운영. 본사 소재지는 New York City, NY, 미국. 현재 CEO는 Eli Decatur Casdin.
CMLFU 을(를) 보유 IPO 날짜 2020-09-02, 에 상장 NASDAQ Capital Marke, 시가총액 $10.31B.
CM Life Sciences, Inc. is a special purpose acquisition company (SPAC) founded in 2020 and headquartered in New York, New York. The company was established to identify and execute a merger or business combination with one or more operating companies, potentially involving capital stock exchanges, asset acquisitions, or stock purchases. Through this acquisition strategy, CM Life Sciences seeks to create value in the life sciences sector by combining with established or emerging businesses.
